AXGN Axogen, Inc. - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
AXGN Stock | Fundamental Analysis & Investment Insights
NASDAQ
Healthcare
Medical Devices
Current Price
Live
$32.83
Analyst Target
$37.0
+12.7%
Upside
52W High
$34.71
52W Low
$9.22
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
65%
Analysis Accuracy
AXGN exhibits a weak Piotroski F-Score of 4/9, indicating marginal financial health, and lacks an Altman Z-Score, limiting distress risk assessment. Despite strong revenue growth of 23.5% and improving profitability trends, the company remains unprofitable on a net basis with negative ROE and no meaningful cash flow data. Valuation metrics are stretched, with a high forward P/E of 65.88 and a Price/Book of 12.53, while insider selling of $10.58M in the last six months raises caution. Analysts maintain a strong_buy recommendation, but recent earnings volatility and lack of profitability temper bullish sentiment.
Key Strengths
Strong revenue growth (23.5% YoY) outpaces sector average of 40.81% despite smaller scale
High gross margin of 74.76% reflects pricing power and low production costs
Solid balance sheet with current ratio of 4.09 and quick ratio of 2.38 indicating strong liquidity
Improving operating margin at 3.18%, showing progress toward profitability
Analyst consensus is strong_buy with a $37.00 target price, implying 12.7% upside
Key Risks
Piotroski F-Score of 4/9 indicates weak financial health and inconsistent profitability
Negative net profit margin (-0.98%) and ROE (-1.91%) suggest ongoing earnings challenges
Lack of Altman Z-Score prevents clear assessment of bankruptcy risk
Insider selling of $10.58M in last 6 months signals bearish sentiment from leadership
High valuation with forward P/E of 65.88 and Price/Book of 12.53 makes stock vulnerable to multiple contraction
AI Fair Value Estimate
Based on comprehensive analysis
$28.5
-13.2% below current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare AXGN against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning AXGN from our newsroom.
Newest → oldest
No matching news yet.